Achieve Life Sciences, Inc.
ACHV· Nasdaq
ACHVAchieve Life Sciences, Inc.
Filed Mar 11, 2021 · 10-K · 70 days after period end · 0001564590-21-012523
| Metric | Q4 2020 | Q4 2019 | Q4 2018 | Q4 2017 |
|---|---|---|---|---|
| Net Income | -$4.72M | -$3.19M | -$3.64M | -$3.74M |
| EPS Diluted | -$1.11 | -$5.91 | -$0.55 | -$3.17 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Achieve Life Sciences, Inc. · CIK 949858 · Engraved from SEC EDGAR
ended Dec 31, 2020 · filed Mar 11, 2021 · 70 d after period end
